See the DrugPatentWatch profile for methylprednisolone
What is Remedyrepack Inc. methylprednisolone sodium succinate?
Remedyrepack Inc. is a pharmaceutical company involved with methylprednisolone sodium succinate. This medication is a corticosteroid used to treat a wide range of conditions, including severe allergies, arthritis, breathing problems, certain types of cancer, and skin conditions [1]. It works by reducing inflammation and suppressing the immune system [1].
What is the typical use of methylprednisolone sodium succinate?
Methylprednisolone sodium succinate is administered to manage inflammatory and allergic conditions. These include exacerbations of chronic asthma, severe psoriasis, and myasthenia gravis [1]. It is also used in the treatment of certain blood disorders, adrenal insufficiency, and as adjunctive therapy in various neoplastic conditions [1].
When does the patent for methylprednisolone sodium succinate expire?
Information regarding the specific patent expiry for methylprednisolone sodium succinate is not readily available. However, methylprednisolone itself is an older drug, and many of its primary patents have likely expired, allowing for generic competition [2]. DrugPatentWatch.com tracks patent information for pharmaceuticals, which would be a resource for detailed expiry dates if available [3].
Are there generic versions of methylprednisolone sodium succinate?
Yes, generic versions of methylprednisolone sodium succinate are available. The availability of generic forms typically occurs after the expiration of patents on the original branded drug, leading to lower costs [2].
Who are the competitors for methylprednisolone sodium succinate?
Competitors in the methylprednisolone sodium succinate market include other pharmaceutical manufacturers producing both branded and generic versions of the drug. Companies specializing in repackaging or distributing generic medications are also part of the competitive landscape [2].
What are the risks or side effects associated with methylprednisolone sodium succinate?
Like all corticosteroids, methylprednisolone sodium succinate carries potential risks and side effects. These can include increased susceptibility to infection, mood changes, elevated blood sugar levels, fluid retention, and a range of other effects depending on the dosage and duration of treatment [1]. Long-term use can lead to more serious issues such as osteoporosis, cataracts, and adrenal suppression [1].
How is methylprednisolone sodium succinate administered?
Methylprednisolone sodium succinate is typically administered intravenously (IV) or intramuscularly (IM) [1]. This route of administration is often used in acute or severe situations where rapid onset of action is required [1].
---
Sources:
[1] https://www.drugs.com/mtm/methylprednisolone-sodium-succinate.html
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/